Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with Carboplatin/Paclitaxel in Advanced Ovarian Cancer
NCT02312661Phase 1Completed
- Sponsor
- University Medical Center Groningen
- Start
- Oct 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of metformin in epithelial ovarian cancer (EOC), sponsored by University Medical Center Groningen. Primary endpoint: Number of participants with Adverse Events. Started Oct 2015; status: completed.
02
Drugs
metformin
03
Conditions
epithelial ovarian cancer (EOC)
Beyond the preview
Go deeper on NCT02312661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02312661.